Answers are grounded in this paper and cite their sources.
Background: Respiratory distress syndrome (RDS) is an important cause of early neonatal morbidity and mortality, especially among preterm and low-birth-weight neonates. Prolactin has been suggested to support fetal lung maturation by promoting surfactant phospholipid synthesis. This study assessed maternal and cord blood prolactin levels and their relation with RDS in newborns. Methods: This prospective observational study was conducted in the Department of Obstetrics and Gynaecology, Sardar Patel Medical College and Associated Group of Hospitals, Bikaner, over six months from December 2025 to May 2026. A total of 100 pregnant women were included, with 50 high-risk pregnancies and 50 normal pregnancies. Maternal venous blood and mixed umbilical cord blood were collected around delivery and analyzed for serum prolactin by fluorescence immunoassay. Neonates were assessed for birth weight, APGAR scores, RDS by Downes score, NICU admission and outcome. Results: Maternal serum prolactin was significantly lower in high-risk pregnancies than normal pregnancies (184.6 +/- 52.8 vs 236.8 +/- 61.3 ng/mL, p=0.001). Cord blood prolactin was also lower in high-risk neonates (212.4 +/- 68.5 vs 298.7 +/- 74.2 ng/mL, p=0.001). RDS was more common in high-risk pregnancies (38.0%) than normal pregnancies (10.0%, p=0.001). Neonates with low cord prolactin <250 ng/mL had higher RDS (37.5%), low 5-minute APGAR (25.0%) and NICU admission (45.8%). Conclusion: Low maternal and cord blood prolactin levels were significantly associated with increased neonatal RDS and morbidity. Cord blood prolactin may be useful as an early biochemical marker for identifying newborns at risk of respiratory distress.
No takes yet. Share an insight, caveat, or question.
Bunker et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: